https://microbiologyinhibitors.....com/nodaltgf%ce%b2-
Just a limited quantity of studies have already been published up to now on the outcomes of insulin on EGFR-TKI resistance in NSCLC. Therefore, the aim of the current study would be to explore the functions of hyperinsulinemia and hyperglycemia in mediating gefitinib resistance in NSCLC cells with activating EGFR mutations. In today's study, the HCC4006 mobile line, which harbors EGFR mutations, was co-treated
Like
Comment
Share
